| Net sales | 187.85M |
| Cost of sales | 108.98M |
| Gross profit | 78.88M |
| Selling expense | 55.87M |
| General and administrative expense | 19.85M |
| Research and development expense | 8.42M |
| Total operating expenses | 84.14M |
| Income (loss) from operations | -5.27M |
| Other expense, net | 1.25M |
| Income (loss) before income taxes | -4.45M |
| Provision for income taxes (Note 3) | 1.29M |
| Net income (loss) | -5.87M |
| Dividends on convertible preferred stock | |
| Net income (loss) allocable to common shareholders | |
| Basic | -0.06 |
| Diluted | -0.06 |
| Basic | 94.08M |
| Diluted | 94.08M |